PGFC
MRNA icon

Peapack-Gladstone Financial Corp’s Moderna MRNA Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,890
Closed -$230K – 708
2023
Q2 		$230K Sell
1,890
-210
-10% -$28K ﹤0.01% 617
2023
Q1 		$323K Hold
2,100
– – 0.01% 545
2022
Q4 		$377K Hold
2,100
– – 0.01% 505
2022
Q3 		$248K Hold
2,100
– – 0.01% 578
2022
Q2 		$300K Hold
2,100
– – 0.01% 515
2022
Q1 		$362K Sell
2,100
-3
-0.1% -$505 0.01% 531
2021
Q4 		$534K Sell
2,103
-9
-0.4% -$2.63K 0.01% 459
2021
Q3 		$813K Buy
+2,112
New +$779K 0.02% 398

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Peapack-Gladstone Financial Corp's MRNA Position: Q3 2023 in Review

Peapack-Gladstone Financial Corp sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,890 shares — an estimated $230K sold.

Peapack-Gladstone Financial Corp first reported a position in MRNA in Q3 2021 and held it in 8 quarters. The position peaked at $813K in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Peapack-Gladstone Financial Corp reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 1,890 Moderna shares in Q3 2023, an estimated $230K.
  • Peapack-Gladstone Financial Corp first reported a position in Moderna in Q3 2021 and held it in 8 quarters.
  • Peapack-Gladstone Financial Corp's Moderna position peaked at $813K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q3 2023, filed 14 Nov 2023.